Valley National Advisers Inc Bio Techne Corp Transaction History

Valley National Advisers Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$62.12 - $84.15 $1,863 - $2,524	-30 Reduced 15.79%	160 $11,000
Q1 2024 Apr 19, 2024	SELL	$65.98 - $77.09 $1,319 - $1,541	-20 Reduced 9.52%	190 $13,000
Q4 2023 Jan 25, 2024	BUY	$52.83 - $78.22 $5,283 - $7,822	100 Added 90.91%	210 $16,000
Q3 2023 Nov 13, 2023	BUY	$67.52 - $89.42 $6,752 - $8,942	100 Added 1000.0%	110 $7,000
Q2 2023 Jul 31, 2023	BUY	$73.76 - $85.98 $737 - $859	10 New	10 $1,000

619

156M

161K

12.7K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.4B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Valley National Advisers Inc with notifications on news.